{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:23:22Z","timestamp":1775064202067,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.nmd.2012.12.003","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T08:16:54Z","timestamp":1358324214000},"page":"319-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement"],"prefix":"10.1016","volume":"23","author":[{"given":"Lisa D.","family":"Hobson-Webb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2012.12.003_b0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2012.12.003_b0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe\u2019s disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2012.12.003_b0015","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltose) deficiency","author":"Hirschhorn","year":"2001"},{"key":"10.1016\/j.nmd.2012.12.003_b0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10545-011-9393-6","article-title":"Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study","volume":"35","author":"Furusawa","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2012.12.003_b0175","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clineuro.2010.12.005","article-title":"Adult Pompe disease: clinical manifestations and outcome of the first Greek patients receiving enzyme replacement therapy","volume":"113","author":"Papadimas","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nmd.2012.12.003_b0180","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20019","article-title":"Enzyme replacement therapy in late-onset Pompe\u2019s disease: a three-year follow-up","volume":"55","author":"Winkel","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2012.12.003_b0185","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nmd.2010.07.277","article-title":"Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study","volume":"20","author":"van Capelle","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2012.12.003_b0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1468-1331.2008.02377.x","article-title":"Glycogen storage disease type II (Pompe disease)\u2013influence of enzyme replacement therapy in adults","volume":"16","author":"Merk","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2012.12.003_b0190","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1212\/01.wnl.0000249183.39952.3e","article-title":"Ptosis as a feature of late-onset glycogenosis type II","volume":"67","author":"Groen","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2012.12.003_b0195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/WNO.0b013e3181f9a923","article-title":"Ptosis in Pompe disease: common genetic background in infantile and adult series","volume":"30","author":"Ravaglia","year":"2010","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.nmd.2012.12.003_b0055","doi-asserted-by":"crossref","unstructured":"Ravaglia S, Repetto A, De Filippi P, Danesino C. Ptosis as a feature of late-onset glycogenosis type II. Neurology 2007;69:116; author reply 116.","DOI":"10.1212\/01.wnl.0000270101.95790.fb"},{"key":"10.1016\/j.nmd.2012.12.003_b0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/01676830.2010.546932","article-title":"Ptosis, extraocular motility disorder, and myopia as features of pompe disease","volume":"30","author":"Slingerland","year":"2011","journal-title":"Orbit"},{"key":"10.1016\/j.nmd.2012.12.003_b0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WNO.0b013e3181ce162a","article-title":"Improvement of bilateral ptosis on higher dose enzyme replacement therapy in Pompe disease","volume":"30","author":"Yanovitch","year":"2010","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.nmd.2012.12.003_b0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3928\/01913913-20100106-08","article-title":"Clinical and histologic ocular findings in pompe disease","volume":"47","author":"Yanovitch","year":"2010","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.nmd.2012.12.003_b0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymgme.2010.06.003","article-title":"Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients","volume":"101","author":"Bernstein","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2012.12.003_b0080","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","article-title":"Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients","volume":"17","author":"Muller-Felber","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2012.12.003_b0085","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/mus.22202","article-title":"Expanding the phenotype of late-onset pompe disease: Tongue weakness: A new clinical observation","volume":"44","author":"Dubrovsky","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2012.12.003_b0220","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mus.880100311","article-title":"The pattern of involvement of adult-onset acid maltase deficiency at autopsy","volume":"10","author":"van der Walt","year":"1987","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2012.12.003_b0225","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.clinph.2011.04.016","article-title":"The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findings","volume":"122","author":"Hobson-Webb","year":"2011","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nmd.2012.12.003_b0230","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00455-011-9328-2","article-title":"Age and sex differences in orofacial strength","volume":"27","author":"Clark","year":"2012","journal-title":"Dysphagia"},{"key":"10.1016\/j.nmd.2012.12.003_b0105","unstructured":"Iowa Oral Performance Instrument Model 2.2. ed. IOPI User Manual.: IOPI Medical LLC; Carnation, WA."},{"key":"10.1016\/j.nmd.2012.12.003_b0110","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/archneur.1992.00530360057018","article-title":"Validation of the 3-oz water swallow test for aspiration following, stroke","volume":"49","author":"DePippo","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2012.12.003_b0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1044\/1058-0360(2008\/07-0010)","article-title":"The communicative effectiveness survey: preliminary evidence of construct validity","volume":"17","author":"Donovan","year":"2008","journal-title":"Am J Speech Lang Pathol"},{"key":"10.1016\/j.nmd.2012.12.003_b0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10545-011-9404-7","article-title":"Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy","volume":"35","author":"van Gelder","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2012.12.003_b0240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00455-009-9252-x","article-title":"Oropharyngeal dysphagia in infants and children with infantile Pompe disease","volume":"25","author":"Jones","year":"2010","journal-title":"Dysphagia"},{"key":"10.1016\/j.nmd.2012.12.003_b0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0029-1231066","article-title":"Treatment of gastroesophageal reflux with nissen fundoplication and gastrostomy tube insertion in infantile pompe\u2019s disease","volume":"40","author":"Hirschburger","year":"2009","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2012.12.003_b0135","first-page":"147","article-title":"Jones, Harrison H.N., O\u2019Grady G., Suarez A.H., Heller J.H., Kishani P.K. Language and speech function in children with infantile Pompe Disease","volume":"7","author":"Muller","year":"2009","journal-title":"J Pediatr Neurol"},{"key":"10.1016\/j.nmd.2012.12.003_b0245","first-page":"50","article-title":"Adult-onset acid maltase deficiency with prominent bulbar involvement and ptosis","volume":"86","author":"Barnes","year":"1993","journal-title":"J R Soc Med"},{"key":"10.1016\/j.nmd.2012.12.003_b0250","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ymgme.2011.04.009","article-title":"Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered","volume":"103","author":"El-Gharbawy","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2012.12.003_b0150","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2012.12.003_b0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2010.01.015","article-title":"Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case","volume":"100","author":"Kobayashi","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2012.12.003_b0255","first-page":"1533","article-title":"Adult-onset acid maltase deficiency in siblings","volume":"35","author":"Miyamoto","year":"1985","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.nmd.2012.12.003_b0165","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.nmd.2011.06.748","article-title":"Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns","volume":"21","author":"Carlier","year":"2011","journal-title":"Neuromuscul Disord"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896612007018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896612007018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:00:45Z","timestamp":1760774445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896612007018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0960896612007018"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2012.12.003","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2012.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}